Garcia-Valdecasas J, Bernal C, Cerezo S, Garcia F, Montiel N, Leyva A, Umana W O, Bosch J P
Department of Medicine, Hospital Universitario, University of Granada, Spain.
ASAIO J. 1994 Jul-Sep;40(3):M450-3. doi: 10.1097/00002480-199407000-00040.
This study was performed in patients with hepatitis C virus (HCV) who were treated with hemodialysis to determine the relationships among alanine amino-transferase (ALT) levels, immunoglobulin (Ig) G anti-HCV, IgM anti-HCV core, and HCV RNA. Of 107 patients on hemodialysis, 27 had positive IgG anti-HCV. Eight of the patients who had HCV were evaluated every 8 months during a period of 2 years, using the following selection criteria: positive IgG against c-22, c33-c, 5-1-1, and c100-3 viral peptides; absence of infection by hepatitis A virus, hepatitis B virus, cytomegalo-virus, Epstein-Barr virus, herpes simplex virus, and human immunodeficiency virus, as well as absence of hepatotoxic drugs or cholelithiasis. We considered elevated ALT values as those more than 150% of the upper limit of normal. Three of the patients had persistent elevation of ALT levels, two had alternating elevation of ALT levels, and three had normal ALT levels in all blood samples. Of the 24 blood samples, 11 had elevation of ALT (45.8%) levels that showed positive IgM anti-HCV, but only 7 of these 11 had positive HCV RNA (63.6%). None of the 13 blood samples without elevation of ALT had positive IgM anti-HCV, but 5 had positive HCV RNA (38.5%). We found an excellent correlation between IgM anti-HCV and ALT levels (r = 0.81). There was no statistically significant difference between the mean ALT values on the 12 blood samples that had positive HCV RNA and the mean ALT values of the negative HCV RNA samples (53.5 +/- 28.0 IU/l vs. 37.4 +/- 17.5 IU/l, respectively). IgM anti-HCV is related to the elevation of ALT levels and can be used as a serologic marker to indicate the presence of active HCV induced liver damage. Serum ALT levels do not correlate with the detection of viral genome in sera. IgG anti-HCV is not necessarily associated with HCV RNA or IgM anti-HCV. The absence of IgM and HCV RNA in patients with IgG anti-HCV and normal ALT levels does not necessarily suggest the absence of active HCV infection.
本研究在接受血液透析治疗的丙型肝炎病毒(HCV)患者中进行,以确定丙氨酸氨基转移酶(ALT)水平、免疫球蛋白(Ig)G抗-HCV、IgM抗-HCV核心抗体和HCV RNA之间的关系。在107例接受血液透析的患者中,27例IgG抗-HCV呈阳性。对8例HCV阳性患者在2年期间每8个月进行一次评估,采用以下选择标准:针对c-22、c33-c、5-1-1和c100-3病毒肽的IgG呈阳性;无甲型肝炎病毒、乙型肝炎病毒、巨细胞病毒、爱泼斯坦-巴尔病毒、单纯疱疹病毒和人类免疫缺陷病毒感染,以及无肝毒性药物或胆石症。我们将ALT值升高定义为超过正常上限的150%。其中3例患者ALT水平持续升高,2例患者ALT水平交替升高,3例患者所有血样的ALT水平均正常。在24份血样中,11份ALT水平升高(45.8%),其IgM抗-HCV呈阳性,但这11份中只有7份HCV RNA呈阳性(63.6%)。13份ALT未升高的血样中,无一例IgM抗-HCV呈阳性,但5份HCV RNA呈阳性(38.5%)。我们发现IgM抗-HCV与ALT水平之间存在极好的相关性(r = 0.81)。HCV RNA阳性的12份血样的平均ALT值与HCV RNA阴性血样的平均ALT值之间无统计学显著差异(分别为53.5 +/- 28.0 IU/l和37.4 +/- 17.5 IU/l)。IgM抗-HCV与ALT水平升高有关,可作为血清学标志物来指示是否存在活动性HCV诱导的肝损伤。血清ALT水平与血清中病毒基因组的检测无关。IgG抗-HCV不一定与HCV RNA或IgM抗-HCV相关。IgG抗-HCV且ALT水平正常的患者中无IgM和HCV RNA,不一定表明不存在活动性HCV感染。